MOLINA ARTURO MD
Insider CIK 1398940 · PTGX Chief Medical Officer · STRO Chief Medical Officer · FMTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-03-26 | 2026-03-27 | 15,000 | — | $0 | 50,971 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-03-26 | 2026-03-27 | 15,000 | $8.04 | $120.6K | 99,115 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-03-26 | 2026-03-27 | 15,000 | $104.79 | $1.57M | 84,115 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-01-27 | 2026-01-27 | 5,000 | — | $0 | 65,971 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-01-27 | 2026-01-27 | 5,000 | $8.04 | $40.2K | 89,115 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-01-27 | 2026-01-27 | 5,000 | $82.00 | $410.0K | 84,115 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-01-26 | 2026-01-27 | 5,000 | — | $0 | 70,971 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-01-26 | 2026-01-27 | 5,000 | $8.04 | $40.2K | 89,115 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-01-26 | 2026-01-27 | 5,000 | $82.28 | $411.4K | 84,115 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-01-23 | 2026-01-27 | 13,151 | $82.42 | $1.08M | 84,115 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-01-20 | 2026-01-21 | 9,514 | $82.48 | $784.7K | 97,266 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2026-01-02 | 2026-01-06 | 32,000 | — | $0 | 32,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2026-01-02 | 2026-01-06 | 25,600 | — | $0 | 106,780 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-11-17 | 2025-11-19 | 2,712 | $84.77 | $229.9K | 81,180 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2025-06-10 | 2025-06-11 | 10,000 | — | $0 | 75,971 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-06-10 | 2025-06-11 | 10,000 | $57.03 | $570.3K | 83,892 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2025-06-10 | 2025-06-11 | 10,000 | $8.04 | $80.4K | 93,892 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2025-06-09 | 2025-06-11 | 10,000 | — | $0 | 85,971 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2025-06-09 | 2025-06-11 | 10,000 | $8.04 | $80.4K | 93,892 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-06-09 | 2025-06-11 | 10,000 | $55.51 | $555.1K | 83,892 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2025-03-13 | 2025-03-14 | 2,077 | — | $0 | 47,785 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2025-03-13 | 2025-03-14 | 28,437 | — | $0 | 69,063 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2025-03-13 | 2025-03-14 | 28,437 | $23.42 | $666.0K | 112,329 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-03-13 | 2025-03-14 | 30,514 | $55.74 | $1.70M | 83,892 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2025-03-13 | 2025-03-14 | 2,077 | $38.98 | $81.0K | 114,406 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-01-16 | 2025-01-17 | 388 | — | $0 | 87,144 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-01-16 | 2025-01-17 | 3,252 | — | $0 | 83,892 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2025-01-02 | 2025-01-06 | 49,862 | — | $0 | 49,862 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2025-01-02 | 2025-01-06 | 41,088 | — | $0 | 87,532 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-11-27 | 2024-11-27 | 10,000 | — | $0 | 111,971 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-11-27 | 2024-11-27 | 16,000 | — | $0 | 95,971 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-11-27 | 2024-11-27 | 16,000 | $44.83 | $717.3K | 46,444 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-11-27 | 2024-11-27 | 10,000 | $8.04 | $80.4K | 56,444 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-11-27 | 2024-11-27 | 10,000 | $44.50 | $445.0K | 46,444 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-11-27 | 2024-11-27 | 16,000 | $8.04 | $128.6K | 62,444 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-11-26 | 2024-11-27 | 5,529 | — | $0 | 121,971 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-11-26 | 2024-11-27 | 5,529 | $8.04 | $44.5K | 51,973 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-11-26 | 2024-11-27 | 5,529 | $45.60 | $252.1K | 46,444 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-11-15 | 2024-11-19 | 1,906 | $40.98 | $78.1K | 46,444 | SEC↗ |
| PTGX Protagonist Therapeutics, | F Tax w/h | 2024-01-16 | 2024-01-18 | 427 | $24.63 | $10.5K | 48,350 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2024-01-02 | 2024-01-04 | 97,500 | — | $0 | 97,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2024-01-02 | 2024-01-04 | 26,250 | — | $0 | 48,777 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2023-11-15 | 2024-01-04 | 1,848 | $16.24 | $30.0K | 22,527 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2023-01-16 | 2023-01-18 | 18,750 | — | $0 | 18,750 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2023-01-16 | 2023-01-18 | 3,125 | — | $0 | 24,375 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2022-11-15 | 2022-11-17 | 127,500 | — | $0 | 127,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2022-11-15 | 2022-11-17 | 21,250 | — | $0 | 21,250 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 16,750 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | U Tender | 2022-10-14 | 2022-10-14 | 10,000 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 10,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2022-03-05 | 2022-03-07 | 12,500 | — | $0 | 37,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2022-03-05 | 2022-03-07 | 12,500 | — | $0 | 42,091 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2022-03-05 | 2022-03-07 | 4,355 | $8.17 | $35.6K | 37,736 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2022-03-04 | 2022-03-07 | 39,000 | — | $0 | 39,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2022-03-04 | 2022-03-07 | 52,000 | — | $0 | 52,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2022-01-29 | 2022-02-01 | 5,250 | — | $0 | 10,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2022-01-29 | 2022-02-01 | 5,250 | — | $0 | 31,742 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2022-01-29 | 2022-02-01 | 2,151 | $10.39 | $22.3K | 29,591 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2022-01-12 | 2022-01-13 | 16,750 | — | $0 | 16,750 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award | 2022-01-12 | 2022-01-13 | 5,500 | — | $0 | 5,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2021-09-24 | 2021-09-28 | 8,609 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2021-09-24 | 2021-09-28 | 2,976 | $19.23 | $57.2K | 26,492 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2021-09-24 | 2021-09-28 | 8,609 | — | $0 | 29,468 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2021-03-05 | 2021-03-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2021-03-05 | 2021-03-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2021-01-29 | 2021-02-01 | 5,250 | — | $0 | 15,750 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2021-01-29 | 2021-02-01 | 5,250 | — | $0 | 22,966 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2021-01-29 | 2021-02-01 | 2,107 | $22.15 | $46.7K | 20,859 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2020-09-25 | 2020-09-28 | 8,609 | — | $0 | 8,609 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2020-09-25 | 2020-09-28 | 2,976 | $10.30 | $30.7K | 17,716 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2020-09-25 | 2020-09-28 | 8,609 | — | $0 | 20,692 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | P Buy | 2020-05-14 | 2020-05-14 | 6,451 | $7.75 | $50.0K | 12,083 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2020-01-29 | 2020-01-31 | 21,000 | — | $0 | 21,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2020-01-29 | 2020-01-31 | 47,500 | — | $0 | 47,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2019-09-26 | 2019-09-30 | 8,608 | — | $0 | 17,218 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2019-09-26 | 2019-09-30 | 8,608 | — | $0 | 8,608 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2019-09-26 | 2019-09-30 | 2,976 | $9.74 | $29.0K | 5,632 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2019-01-29 | 2019-01-31 | 47,500 | — | $0 | 47,500 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | A Award deriv | 2018-09-26 | 2018-09-27 | 25,826 | — | $0 | 25,826 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | A Award deriv | 2018-09-26 | 2018-09-27 | 154,958 | — | $0 | 154,958 | SEC↗ |